Active	Status	Sponsor type	Region	Phase	Filter
4 Active 13 Inactive 17 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Memoli, Matthew J
NCT05027932: Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine	Completed	1	45	US	IN Placebo, IM Placebo, BPL-1357	National Institute of Allergy and Infectious Diseases (NIAID)	Influenza	03/24	03/24
NCT05436444: Low Pathogenicity Avian H10N7 Influenza Virus in a Healthy Human Challenge Model	Completed	1	35	US	A/Mallard/Ohio-99/MM4/1989 H10N7	National Institute of Allergy and Infectious Diseases (NIAID)	Influenza Infection	12/24	12/24
NCT01386424: Screening for LID Clinical Studies Unit Healthy Volunteer Protocols	Recruiting	N/A	5000	US		National Institute of Allergy and Infectious Diseases (NIAID)	Zika, Influenza
NCT05266222: Respiratory Virus Sampling and Repository	Recruiting	N/A	20000	US		National Institute of Allergy and Infectious Diseases (NIAID)	Influenza, COVID-19	12/31	12/31

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Memoli, Matthew J
NCT05027932: Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine	Completed	1	45	US	IN Placebo, IM Placebo, BPL-1357	National Institute of Allergy and Infectious Diseases (NIAID)	Influenza	03/24	03/24
NCT05436444: Low Pathogenicity Avian H10N7 Influenza Virus in a Healthy Human Challenge Model	Completed	1	35	US	A/Mallard/Ohio-99/MM4/1989 H10N7	National Institute of Allergy and Infectious Diseases (NIAID)	Influenza Infection	12/24	12/24
NCT01386424: Screening for LID Clinical Studies Unit Healthy Volunteer Protocols	Recruiting	N/A	5000	US		National Institute of Allergy and Infectious Diseases (NIAID)	Zika, Influenza
NCT05266222: Respiratory Virus Sampling and Repository	Recruiting	N/A	20000	US		National Institute of Allergy and Infectious Diseases (NIAID)	Influenza, COVID-19	12/31	12/31